Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET[1] ...

New approval provides hospitals and clinics in the Czech Republic with access to a proven PSMA-PET imaging agent MELBOURNE, Australia, May 5, 2025 /PRNewswire/ -- Telix Pharmaceuticals ...

Luke Bantoft has survived melioidosis but the experience has left him "petrified" of returning to his home where he believes ...

Radiation from CT scans may cause as many as 5% of cancers diagnosed each year in the United States, research suggests.